-
Summer 2018 | Live Blog | Management of Eyelid Malignancies
Day 2 of the SDPA Summer Conference ended with an illuminating lecture on eyelid malignancies by Dr. Michael Yen, an oculoplastic surgeon. The most common eyelid malignancy is basal cell cancer representing 95% of eyelid malignancies. Suspicious characteristics for eyelid malignancies include growth, lid notching, ulceration, telangiectasias and deepening pigmentation. […]
June 29, 2018
-
Summer 2018 | Live Blog | Orocutaneous Disease: Review and Update
Dr. John Wright, an oral pathologist, presented an illuminating lecture on orocutaneous disease at the SDPA Annual Summer Conference. Dr. Wright began his talk with viral presentations of disease focusing on herpes simplex virus (HSV). Herpes simplex is a systemic virus which presents as a vesiculobullous disease. With primary herpes […]
June 29, 2018
-
Summer 2018 | Live Blog | Product Theater | Are Your Topical Patients Systemic Ready? An Oral Treatment Option for Moderate to Severe Plaque Psoriasis
The second product theater on day 2 of the SDPA Annual Summer Conference presented by Robert Casquejo, PA-C discussed Otezla as a treatment for adult patients with active psoriatic arthritis and patients with moderate to severe plaque psoriasis who are candidates for phototherapy and systemic therapy. Otezla is an oral […]
June 29, 2018
-
Summer 2018 | Live Blog | Product Theater | Innovations in Dermatology
The first product theater on day 2 of the SDPA Annual Summer Conference was presented by Dr. Neal Bhatia and featured the use of Onexton and Retin-A Micro for the treatment of acne. Acne vulgaris is an inflammatory pilosebaceous disease that affects greater than 80% adolescents, up to 12% women, […]
June 29, 2018
-
Summer 2018 | Live Blog | Nephrocutaneous Disease: Review and Update
Day 2 of the SDPA Annual Summer Conference started with an enlightening lecture on nephrocutaneous disease presented by Dr. Jennie Clarke. For reasons that are not completely understood, xerosis and pruritis are the two most common presentations of patients with end stage renal disease. Unfortunately, dialysis does not help improve […]
June 29, 2018
-
Summer 2018 | Live Blog | Product Theater | More Than Skin Deep with Cosentyx (secukinumab): Proven Effective for Psoriatic Arthritis
Andrea Nguyen, MS, PA-C presented the second product theater on the first day of the SDPA Annual Summer Conference. She discussed Cosentyx, the first and only fully human Il-17A antagonist approved for the treatment of psoriatic arthritis and moderate to severe plaque psoriasis. Cosentyx is also indicated for the treatment […]
June 28, 2018
